Helix BioPharma Corp. to Present at 3rd Annual Immuno-Oncology BD&L and Investment Forum
May 30, 2017 07:30 ET
|
Helix BioPharma Corp.
TORONTO, ON--(Marketwired - May 30, 2017) - Helix BioPharma Corp. (TSX: HBP) (FRANKFURT: HBP) ("Helix" or the "Company"), a clinical stage immuno-oncology company developing innovative drug...
Helix BioPharma Corp. Closes Private Placement
April 27, 2017 16:32 ET
|
Helix BioPharma Corp.
TORONTO, ON--(Marketwired - Apr 27, 2017) - Helix BioPharma Corp. (TSX: HBP) (FRANKFURT: HBP) ("Helix" or the "Company"), an immuno-oncology company developing innovative drug candidates for the...
Helix BioPharma Corp. to Present CAR-T at AACR Annual Meeting 2017 in Washington, D.C.
April 03, 2017 07:45 ET
|
Helix BioPharma Corp.
TORONTO, ON--(Marketwired - Apr 3, 2017) - Helix BioPharma Corp. (TSX: HBP) (FRANKFURT: HBP) ("Helix" or the "Company"), a clinical stage immuno-oncology company developing innovative drug...
L-DOS47 Phase I Study Results To Be Presented at the 9th International Conference of Contemporary Oncology
March 21, 2017 08:00 ET
|
Helix BioPharma Corp.
TORONTO, ON--(Marketwired - Mar 21, 2017) - Helix BioPharma Corp. (TSX: HBP) (FRANKFURT: HBP), a clinical stage immuno-oncology company developing innovative drug candidates for the prevention and...
Helix BioPharma Corp. Announces Strategic Management Changes
March 07, 2017 07:45 ET
|
Helix BioPharma Corp.
TORONTO, ON--(Marketwired - Mar 7, 2017) - Helix BioPharma Corp. (TSX: HBP) (FRANKFURT: HBP) ("Helix" or the "Company"), a clinical stage immuno-oncology company developing innovative drug...
Helix BioPharma Corp. Announces Licence for Worldwide Right to Anti-CEACAM6 Antibody From the Government of Canada
February 27, 2017 07:30 ET
|
Helix BioPharma Corp.
TORONTO, ON--(Marketwired - Feb 27, 2017) - Helix BioPharma Corp. (TSX: HBP) (FRANKFURT: HBP) ("Helix" or the "Company"), a clinical stage immuno-oncology company developing innovative drug...
30Mil CAD$ Investment in European Centre of Cancer Immunotherapy
February 22, 2017 07:30 ET
|
Helix BioPharma Corp.
TORONTO, ON--(Marketwired - Feb 22, 2017) - Helix BioPharma Corp. (TSX: HBP) (FRANKFURT: HBP) ("Helix" or the "Company"), a clinical stage immuno-oncology company developing innovative drug...
Helix BioPharma Corp. Conference Attendance 2017
February 13, 2017 07:45 ET
|
Helix BioPharma Corp.
TORONTO, ON--(Marketwired - Feb 13, 2017) - Helix BioPharma Corp. (TSX: HBP) (FRANKFURT: HBP), a clinical stage immuno-oncology company developing innovative drug candidates for the prevention and...
Helix BioPharma Corp. to Present at the BIO CEO & Investor Conference in New York
February 02, 2017 07:45 ET
|
Helix BioPharma Corp.
TORONTO, ON--(Marketwired - Feb 2, 2017) - Helix BioPharma Corp. (TSX: HBP) (FRANKFURT: HBP), a clinical stage immuno-oncology company developing innovative drug candidates for the prevention and...
Helix BioPharma Corp. Announces CAR-T Poster Presentation at AACR Annual Meeting 2017 in Washington, DC
January 23, 2017 07:45 ET
|
Helix BioPharma Corp.
TORONTO, ON--(Marketwired - Jan 23, 2017) - Helix BioPharma Corp. (TSX: HBP) (FRANKFURT: HBP) ("Helix" or the "Company"), a clinical stage immuno-oncology company developing innovative drug...